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Background: The reported incidence of venous thromboembolism (VTE) varies considerably among studies. The
primary aim of this study was to describe the incidence of VTE in relation to age and sex. The secondary aim was
to describe the risk factor pattern at the time of diagnosis.
Methods: This retrospective, population-based cohort study included all adult residents in the County of Västerbotten
in northern Sweden during the year 2006 (n = 204,836). All potential VTE events were manually validated and classified
according to location. The presence of risk factors for VTE at the time of diagnosis was recorded.
Results: We identified 517 adult individuals with potential VTE. Among these, 343 individuals (158 men and 185
women) had a verified VTE event in 2006. The mean incidence was 167 individuals per 100,000 person years; 155 for
men and 180 for women. The mean age at diagnosis was 67.6 years in men and 72.5 years in women. The incidence of
VTE increased with age. The incidence was highest in women aged 85 years or more. Pulmonary embolism with or
without concurrent deep vein thrombosis was diagnosed in 161 individuals (46.9%); lower extremity deep vein
thrombosis without concurrent pulmonary embolism was diagnosed in 157 individuals (45.8%); and VTE in another
location was diagnosed in 25 individuals (7.3%). The most common risk factors for VTE were recent hospitalization and
concurrent malignancy.
Conclusion: The incidence of VTE was 167 per 100,000 person years and increased with age. The incidence was
highest among older women. Pulmonary embolism was the most common form of VTE; it affected 47% of individuals
with VTE. Malignancy and hospitalization were the most prevalent risk factors for VTE.
Keywords: Venous thromboembolism, Venous thrombosis, Pulmonary embolism, Deep vein thrombosis, Risk factors,
Incidence, Epidemiology, AdultsBackground
Lower extremity deep vein thrombosis (DVT) and pul-
monary embolism are the two most common disease
manifestations of venous thromboembolism (VTE). VTEs
also manifest as thrombosis of the veins of the central
nervous system, upper extremity DVT, and thrombosis
of the veins of the abdomen, such as portal and renal
vein thrombosis. Examples of previously described risk
factors for VTE are hospitalization, immobilization, re-
cent surgery, and malignancy [1]. The 30-day mortality
was reported to be 6.4% for all patients with VTE, 9.7%
for those with pulmonary embolism, and 4.6% for those
with DVT [2].* Correspondence: johansson.magdalena@gmail.com
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article, unless otherwise stated.The incidence of first-time VTE is reported to vary
considerably; it ranges between 62 and 143 per 100,000
individuals per year [2-8]. Some reports describe varia-
tions in incidence among different ethnicities [9,10]. In
previous studies, the incidence of first-time pulmonary
embolism ranged between 19 and 50 per 100,000 per
year. The incidence of first-time DVT ranged between
38 and 95 per 100,000 per year [2-8].
In Sweden, new diagnostic procedures were widely
introduced at the end of the 1990s. Currently, VTE is
routinely evaluated with computed tomography (CT),
D-dimers, and clinical risk assessments, such as Well’s
score. VTE prophylaxis is also widely used [11,12].
On the other hand, the autopsy rate has declined [13].
These changes may have had an impact on the VTE
incidence.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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dence of VTE in relation to age and sex. The secondary
aim was to describe the risk factor pattern at the time of
diagnosis.
Methods
Case identification and setting
Case identification was performed in the County of
Västerbotten, a sparsely populated area located in
northern Sweden. In 2006, the adult population (age
18 and over) was 204,836, and 22.6% was aged 65 years
or more [14]. The vast majority of residents were
Caucasian. All health care was administered by two district
general hospitals, one university hospital, and their associ-
ated primary healthcare centers.
To include all potential VTE events, we performed an
extensive search for VTE cases in the National Patient
Registry that included ICD-10 diagnosis codes I26, I27.8,
I27.9, I67.6, I80, I81, I82, O08.2, O08.7, O22.5, O22.8,
O22.9 and O22.2, for inpatients, outpatients, and emer-
gency department visits in all three hospitals in the
County of Västerbotten for the year 2006. For compari-
son, we also performed a limited search that included
only the ICD-10 diagnosis codes I26 and I80.1-9. We
also searched the mortality registry maintained by the
Swedish National Board of Health and Welfare to find
individuals whose death certificates stated that the cause
of death was a VTE event. To find additional cases of
VTE that were either not coded or miscoded, we
searched the anticoagulant registry, the radiology regis-
try, and the diagnosis registry (ICD-10 codes I74.3 and
K55.0) at one of the three hospitals in the area.
The study was approved by the Regional Ethics Review
Board of Umeå University.
Case validation and classification
All cases identified as potential VTEs were validated by
reviewing the relevant medical records. Validation and
classification of the VTE events were performed by three
physicians (M.J., L.J., and M.L.). Ambiguities were resolved
by discussion.
A pulmonary embolism was considered verified when
confirmed by pulmonary angiography, CT, magnetic res-
onance imaging (MRI), high probability ventilation-
perfusion, or at autopsy. An individual with a verified
DVT and concomitant symptoms of pulmonary embol-
ism was considered to have pulmonary embolism. A
DVT of the lower or upper extremity was considered
verified when confirmed by venography, ultrasonog-
raphy, CT, MRI, or at autopsy. An abdominal VTE event
was classified as verified when confirmed by venography,
ultrasonography, CT, MRI, or at autopsy. A VTE of the
central nervous system was considered verified when
confirmed by CT, MRI, or at autopsy. In patients withprevious VTEs, a recurrence of VTE required objective
evidence, on an appropriate imaging scan, of a new
thrombosis that was not identified during a previous im-
aging scan.
Individuals were classified into three groups according
to the location of the VTE: a pulmonary embolism, a
lower extremity DVT, or a VTE in another location.
VTEs in other locations included an upper extremity
DVT (defined as thrombosis of the deep upper extremity
veins, the superior vena cava, the internal jugular vein,
the subclavian vein, the innominate vein, or the axillary
veins), a thrombosis of the veins of the abdomen, or a
thrombosis of the veins of the central nervous system.
For each individual, we considered only the first veri-
fied VTE event during the study period. Individuals with
multiple concurrent thrombosis locations were classified
hierarchically into one of the following groups: 1: pul-
monary embolism, 2: lower extremity DVT, or 3: VTE in
another location. Individuals with a verified DVT and
symptoms of pulmonary embolism were classified into
the pulmonary embolism group. The VTE event was also
classified as either a first-time VTE or a recurrent VTE.
The event was classified as recurrent when at least one
previous VTE event (before 2006) was documented.
A lower extremity DVT was classified as iliac when it
was located at or above the inguinal ligament; it was
classified as femoropopliteal when it was located in or
above the popliteal vein, but distal to the inguinal liga-
ment; and it was classified as a calf DVT when it was
located below the popliteal vein. It was classified as mus-
cular vein thrombosis when it was located in a muscular
or perforating vein.
Case characterization
The cases were characterized according to presence of
risk factors for VTE at the time of diagnosis. We re-
corded the use of central venous lines, pharmacological
VTE prophylaxis, or systemic hormone therapy (includ-
ing contraceptives). We also extracted from the medical
records data on recent hospitalization, recent surgery,
recent immobilization for more than 48 hours, recent
plaster cast treatment, pregnancy or postpartum (defined
as the period within 60 days of delivery), recent trauma,
and whether the patient had recently travelled for more
than eight hours. Recent events were defined as those
that occurred within 60 days prior to the onset of VTE
symptoms. We also recorded the presence of a previous
VTE, a family history of VTE in a first degree relative,
and the presence and, when applicable, the type of co-
agulation disorder.
To assess the presence of malignant disease, we con-
ducted a search of the Swedish Cancer Registry. Data for
all malignant diseases detected in Swedish residents
from 1958 to present were available in the registry. In
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care providers; therefore, the coverage rate was high, es-
timated at 96% in 1998 [15].
Statistical analysis
Patient characteristics are described as the mean and
standard deviation or the number and proportion. The
annual incidence of VTE was calculated for each sex and
age strata by dividing the number of cases by the total
number of inhabitants on the first of November, 2006.
Results
Incidence
We identified 343 adult residents of the County of
Västerbotten with a verified diagnosis of VTE in 2006.
The mean age was 67.6 years in men and 72.5 years in
women. The overall proportions of women were 54% for
those under age 80 years and 70% for those 80 and over.
Of the patients with VTE, 281 (81.9%) had a first-time
VTE event. Patient characteristics and risk factors at
diagnosis for these 281 patients are shown in Table 1.
The total incidence of VTE (per 100,000 per year) was
167 overall, 155 in men, and 180 in women. The inci-
dence of VTE increased with age in both men and
women (Figure 1). The incidence of pulmonary embolism
was 78.6 per 100,000 per year. The incidence of lowerTable 1 Patient characteristics and risk factors in 281 patient
All (n = 281) 18-64
Male 128 (45.6) 47 (51
Mean age (years) 70.0 ± 15.2 52.3 ±
Risk factors
Recent hospitalizationa 120 (42.7) 39 (42
Recent surgical interventiona 42 (14.9) 23 (25
Recent immobilization >48 hoursa 42 (14.9) 17 (18
Recent traumaa 15 (5.3) 7 (7.6
Recent cast therapya 5 (1.8) 3 (3.3
Recent travel > 8 hoursa 4 (1.4) 3 (3.3
Concurrent malignancy 88 (31.3) 24 (26
Malignancy diagnosed within 2 years of VTE event 7 (2.5) 2 (2.2
Central venous line 27 (9.6) 13 (14
Positive heredity for VTE 7 (2.5) 5 (5.4
Coagulation disorder 7 (2.5) 7 (7.6
Hormone therapyb 7 (4.6) 5 (11.
Pregnancyb 0 (0) 0 (0)
Postpartumb 1 (0.7) 1 (2.2
No risk factors 116 (41.3) 29 (31
VTE prophylaxis at diagnosis 11 (3.9) 2 (2.2
Values represent the mean ± SD or n (%); VTE = venous thromboembolism.
a = Within 60 days before the VTE event.
b = Percentage of female patients only.extremity DVT without concurrent pulmonary embolism
was 76.6 per 100,000 per year. The yearly incidence rates
of upper extremity DVT, thrombosis of the veins of the
central nervous system, and thrombosis of the veins of
the abdomen were 4.9, 3.9, and 3.4 per 100,000, re-
spectively. The incidence of first-time VTE was 137 per
100,000 per year.
Risk factors
The prevalence of common risk factors for first-time
VTE in different age groups is presented in Table 1. The
most common risk factors were recent hospitalization
and concurrent malignancy. Surgery, immobilization,
and trauma occurred more frequently among those aged
18-64 years compared to the older age groups. Of the pa-
tients with first-time VTE, 11 (3.9%) were taking pharma-
cological VTE prophylaxis at the time of diagnosis. The
proportion of first-time VTE cases with none of the regis-
tered risk factors increased with age, and it comprised 58%
of the oldest age group. The risk factor profile in the 62 pa-
tients with recurrent VTE was similar to the risk factor
profile in the patients with first-time VTE.
Thrombosis location
Of the 343 patients with VTE, 161 had pulmonary em-
bolism, 157 had lower extremity DVTs, 10 had uppers with first-time VTE, grouped by age
years (n = 92) 65-79 years (n = 100) 80 years and over (n = 89)
.1) 54 (54.0) 27 (30.3)
10.8 72.7 ± 4.2 85.5 ± 4.1
.4) 44 (44.0) 37 (41.6)
.0) 11 (11.0) 8 (9.0)
.5) 13 (13.0) 12 (13.5)
) 6 (6.0) 2 (2.2)
) 2 (2.0) 0 (0)
) 1 (1.0) 0 (0)
.1) 45 (45.0) 19 (21.3)
) 4 (4.0) 1 (1.1)
.1) 12 (12.0) 2 (2.2)
) 2 (2.0) 0 (0)
) 0 (0) 0 (0)
1) 0 (0) 2 (3.2)
0 (0) 0 (0)
) 0 (0) 0 (0)
.5) 35 (35.0) 52 (58.4)
) 5 (5.0) 4 (4.5)
Figure 1 Incidence of venous thromboembolism increases with age. Men (blue); women (red).
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the 281 patients with first-time VTE, 135 had pulmonary
embolism, 123 had lower extremity DVTs, 9 had upper
extremity DVTs, and 14 had VTEs at other locations
(Table 2). First-time iliac DVTs occurred most frequently
in the oldest age group, and first-time femoropoplitealTable 2 Location of thrombosis by age group in patients with
Disorder and location All (n = 281) 18-64 years (n
Deep vein thrombosis 132 (47.0) 45 (48.9)
Iliac DVTa 52 (39.4) 8 (17.8)
Femoropopliteal DVTa 46 (34.8) 21 (46.7)
Calf DVTa 20 (15.2) 9 (20.0)
Muscular DVTa 5 (3.8) 3 (6.7)
Upper extremity DVTa 9 (6.8) 4 (8.9)
Pulmonary embolism 135 (48.0) 40 (43.5)
Right side PEb 36 (26.7) 7 (17.5)
Left side PEb 11 (8.1) 2 (5.0)
Bilateral PEb 74 (54.8) 26 (65.0)
Unknown location of PEb 14 (10.4) 5 (12.5)
VTE in another location 14 (5.0) 7 (7.6)
Abdominal VTEc 7 (50.0) 3 (42.9)
Central nervous system VTEc 7 (50.0) 4 (57.1)
Values represent n (%) for each group. DVT = deep vein thrombosis, PE = pulmonary
of embolism, and the list below indicates the specific locations for each type of em
a = Number and percentage of patients with DVT.
b = Number and percentage of patients with PE.
c = Number and percentage of patients with VTE in another location.DVTs occurred most frequently in the youngest age
group. The proportion of first-time pulmonary embolism
increased with increasing age. In patients with first-time
pulmonary embolism, 55% had bilateral emboli. Uni-
lateral first-time pulmonary embolism occurred pre-
dominantly on the right side. First-time VTEs in otherfirst-time VTE
= 92) 65-79 years (n = 100) 80 years and up (n = 89)
47 (47.0) 40 (44.9)
20 (42.6) 24 (60.0)
14 (29.8) 11 (27.5)
8 (17.0) 3 (7.5)
1 (2.1) 1 (2.5)
4 (8.5) 1 (2.5)
48 (48.0) 47 (52.8)
16 (33.3) 13 (27.7)
4 (8.3) 5 (10.6)
21 (43.8) 27 (57.4)
7 (14.6) 2 (4.3)
5 (5.0) 2 (2.2)
4 (80.0) 0 (0)
1 (20.0) 2 (100.0)
embolism, VTE = venous thromboembolism. Bold lettering indicates the type
bolism.
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group. First-time lower extremity DVTs occurred more
frequently on the left-side than on the right-side, in
both men and women. A concurrent verified lower ex-
tremity DVT was found in 19 patients with first-time
pulmonary embolism. Two patients with first-time pul-
monary embolism had symptoms and clinical signs of a
lower extremity DVT. There were seven cases of first-
time abdominal VTE, and seven cases of first-time VTE
in the central nervous system.
Diagnostic method
Of the 161 patients with pulmonary embolism, the diag-
nosis was verified in 133 with CT scans, in 5 with high
probability ventilation/perfusion scans, in 13 by autopsy,
and by clinical signs or symptoms of pulmonary embol-
ism in patients with another verified VTE in 10 patients.
In 21 (13%) of the patients with pulmonary embolism,
the pulmonary embolism was discovered at imaging
performed with another objective than evaluation for
pulmonary embolism. Of the 157 patients with lower ex-
tremity DVTs, the diagnosis was verified in 121 by ultra-
sonography, in 33 by venography, and in 3 with CT
scans. No patient with a lower extremity DVT was diag-
nosed by autopsy only. Of the seven patients with ab-
dominal VTEs, the diagnosis was verified in five with
CT scans and in two by ultrasonography. Of the eight
patients with VTEs in the central nervous system, the diag-
nosis was verified in seven by MRI and in one with a CT
scan. Of the ten patients with upper extremity DVTs, the
diagnosis was verified in six by ultrasonography, in three
by venography, and in one with a CT scan.
Evaluation of search methods
With our extensive ICD-10 code search, we identified
517 adult individuals. Of these, 313 individuals had a
verified VTE event. Therefore, this method of case iden-
tification resulted in 39% false positive cases. Other
sources (the mortality registry, the anticoagulant registry,
the radiology registry, and additional ICD-10 codes,
I74.3 and K55.0) revealed an additional 30 individuals
with VTE. The total number of individuals with verified
VTE was 343. The extensive search method identified
91% of the cases of verified VTE and thus had a false
negative rate of 9%. In the original extensive search, 204
individuals did not have a verified VTE. Of these, some
had other conditions, including superficial thrombophle-
bitis, pulmonary hypertension, arterial thromboembolic
disease, or edema of the lower extremities. Others were
on a medical checkup on a past VTE event. We also
performed a limited search, where we only used the
ICD-10 codes, I26 and I80.1-9, for case identification.
This search resulted in a 36% false positive rate and
a 22% false negative rate for identifying patients withpulmonary embolism and/or DVT of the upper or lower
extremities.
Discussion
This study showed that the incidence of VTE in north-
ern Sweden was 167 per 100,000 per year. The incidence
increased with age and was higher in women. Pulmonary
embolism and lower extremity DVTs were the most
common disease manifestations and had similar inci-
dence rates. In our population, the most common risk
factors for first-time VTE were recent hospitalization
and concurrent malignancy.
We reviewed other studies that presented data on the
incidence of first-time VTEs in different age groups and
for men and women separately (Table 3). The reported
overall incidence varied between 96 and 143 per 100,000
per year [2,3,6-8,16]. Studies that included children and
adolescents generally reported a lower overall incidence,
because VTE is rare in those age groups [6-8,16]. In the
three studies that only included adults, the incidence
rates varied between 130 and 143 per 100,000 per year
[2,3]. In individuals aged 60 years and older, the inci-
dence was considerably higher in the American and
French studies [6-8,16] compared to the other studies.
Potential explanations for this discrepancy may be that
the different studies used different case identification
strategies. We searched the anticoagulant registry, the
radiology registry, and the National Patient Registry for
additional ICD-10 codes in a subset of our population.
This strategy would have yielded an additional 10% of
VTE cases, if applied to our whole population. Never-
theless, the incidence rate in our study would have
remained lower than those reported in the three studies
with the highest incidence rates among individuals aged
60 years and older. On the other hand, we scrutinized
the medical records for the presence of previous VTEs,
and we included only cases of first-time VTEs in the in-
cidence comparisons. Misclassifications of recurrent
VTE cases would have resulted in an overestimation of
the incidence. Alternatively, there may be true variations
in incidence rates among different studies due to differ-
ences in the risk factor patterns among the populations
studied; e.g., prevalence of obesity, smoking habits, and
hereditary risk factors [17-19]. It is notable that the three
Scandinavian studies with comparable populations re-
ported similar incidence rates.
In the reviewed studies, the incidence was (per
100,000 per year) 103 to 151 in men, and 88 to 158 in
women (Table 3) [2,3,6-8,16]. Although the overall inci-
dence of VTE in our study was higher in women than in
men, the incidence of VTE was higher in men than in
women in the 60 to 74 year-old age group. A similar
finding was reported in a Norwegian study [2]. Interest-
ingly, we did not detect any differences in the risk factor











Patients with first-time DVT and/or PE included 267 740 327 464 444 1567
Period of data collection 2006 1995-2001 1994-2007 1998-1999 1986-1990 1999, 2001, 2003
Geographic location Sweden Norway Norway France United States United States
Age at DVT and/or PE diagnosis, yearsa 70 ± 15 73 (22-102) N/A N/A N/A 64.6
Age groups included ≥18 years ≥20 years >24 years All ages All ages All ages
Yearly incidence of first-time DVT and/or PEb 130 143 140 136 96c 114f
Incidence of first-time DVT and/or PE by age groupb
(age range, years)
54 (18-64) 63 (20-64) 54 (<50) 39 (<60) 55 (15-64)d 58 (<65)
270 (65-74) 252 (65-74) 254 (50-69) 354 (60-74) 356 (65-74)d 336 (65-74)
463 (75-84) 529 (75-84) 570 (≥70) 895 (≥75) 628 (75-84)d 538 (75-84)
668 (≥85) 680 (≥85) 818 (≥85)d 781 (≥85)
Yearly incidence of first-time DVT and/or PE in menb 119 128 151 114 107e 103
Yearly incidence of first-time DVT and/or PE in womenb 142 158 131 149 88e 124
Yearly incidence of first-time DVT b 64 93 91 87 49c 95g
Yearly incidence of first-time PEb 66 50 50 46 47c 34h
VTE = venous thromboembolism, DVT = deep vein thrombosis, PE = pulmonary embolism, N/A = data not available.
a = Mean age with standard deviation or median age with age range, according to each study.
b = Incidence per 100,000 person years.
c = Incidence age- and sex adjusted.
d = Incidence for each age group calculated as follows: The total number of female residents in the age group was calculated as: x = number of cases in females/
the incidence in females. The total number of male residents in the age group was calculated as: y = number of cases in males/the incidence in males. Then, the
incidence = the total number of cases in the age group/(x + y).
e = Incidence age adjusted.
f = Age-adjusted VTE incidence rate, all events included.
g = Age-adjusted DVT incidence rate with or without concurrent PE.
h = Age-adjusted PE incidence rate with or without concurrent DVT.
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might explain the difference in incidence. A possible ex-
planation for this finding could be that, compared to men,
women might acquire risk factors at a higher age, and this
may have contributed to a later VTE incidence peak.
In the present study, half of the first-time VTE events
were classified as a pulmonary embolism. This propor-
tion contrasted with findings in most other reviewed
studies, which reported a considerably lower incidence
of pulmonary embolism compared to DVT [2,3,6,8,16].
The high incidence of pulmonary embolism in our study,
compared to other studies, might be attributable to the
different study periods. Over the last decade, the use
and quality of CT scans has improved for disease diag-
nosing and monitoring (e.g., in malignant diseases). An-
other factor that could have contributed to a higher
incidence of pulmonary embolism in our study was our
inclusion of cases of objectively verified, asymptomatic
pulmonary embolism. In one other study, asymptomatic
cases were excluded [3]. In addition, the classifications
for cases with verified DVT and concomitant symptoms
of pulmonary embolism vary between studies. We chose
to classify these cases as pulmonary embolism; however,
in many studies, these cases were classified as DVT
[2,3,7,8]. This can also contribute to a higher incidenceof pulmonary embolism in our study. Finally, the aut-
opsy rate can affect the incidence of pulmonary embol-
ism. In the study by Silverstein et al., performed between
1986 and 1990, the autopsy rate was 30-35%; this high
rate could have contributed to the high incidence of pul-
monary embolism reported in their study [7]. It is
known that the autopsy rate has decreased over time [7].
In the County of Västerbotten, the autopsy rate was 17%
in 2006, and only 13 of the 161 patients with pulmonary
embolism were diagnosed at autopsy.
Recent hospitalization was the most common risk fac-
tor in all age groups, and the proportion of recently hos-
pitalized patients with VTE was similar across all age
groups. In our study, 31% of patients with first-time
VTE had a concurrent malignancy; this proportion was
highest in the 65-79 year-old age group. In comparison,
in the large Worchester VTE study, the proportion of
patients with concurrent malignancy was 30% [8]. Of the
total population of patients with first-time VTE, we
could not identify any risk factor in 41%. This propor-
tion is lower than in other Scandinavian studies [2,3,5],
but higher than in a large American study [8].
The primary strength of our study was the use of an
extensive search method with a wide range of ICD-10
diagnostic codes. This approach enabled the identification
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VTE cases were verified. We also evaluated a limited ICD-
10 code search method with aim of identifying patients
with lower or upper extremity DVTs or pulmonary embol-
ism; again, we verified all cases. The proportion of false
positive cases found with this search method was 36%. In a
Danish study that used a similar limited search method,
the proportion of false positive cases was 42% [20]. This
high proportion of false positive cases emphasizes the im-
portance of case verification when using diagnostic codes
to identify patients with VTE.
Our study was performed in a geographically well-
defined area; we included both inpatient and outpatient
cases of VTE and had no upper age limit for inclusion.
One weakness of the study was the retrospective study
method. We only had access to data available from med-
ical records. Thus, the information about risk factors
and previous VTE events was limited to the content of
the medical records. Due to incomplete information on
risk factors in medical records, it is possible that we have
underestimated the prevalence of risk factors at time of
VTE diagnosis. Another limitation was that our results
were based on a limited number of VTE events, which
restricted the power to detect small differences between
groups.
Conclusion
The incidence of VTE was 167 per 100,000 person years,
and it increased with age. The incidence was highest
among older women. Malignancy and hospitalization
were the most prevalent risk factors for VTE. We found
a high incidence of pulmonary embolism compared to
other studies.
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